First Allied Advisory Services’s Pacific Biosciences PACB Stock Holding History

First Allied Advisory Services’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-16,669	Closed	-$117K	–	1084
2016 Q2	$117K	Buy	16,669 +680	+4%	+$6.21K	0.01%	989
2016 Q1	$136K	Buy	15,989 +304	+2%	+$2.99K	0.01%	944
2015 Q4	$206K	Buy	+15,685	New	+$141K	0.01%	956
2014 Q3	–	Sell	-35,932	Closed	-$221K	–	1081
2014 Q2	$221K	Buy	35,932 +13,115	+57%	+$65.6K	0.02%	847
2014 Q1	$120K	Buy	+22,817	New	+$144K	0.01%	938

Other funds holding PACB

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCM

Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

First Allied Advisory Services's PACB Position: Q3 2016 in Review

First Allied Advisory Services sold out of Pacific Biosciences (PACB) in Q3 2016, closing a stake of 16,669 shares — an estimated $117K sold.

First Allied Advisory Services first reported a position in PACB in Q1 2014 and held it in 5 quarters. The position peaked at $221K in Q2 2014. 128 funds tracked by Wall St. Rank hold PACB as of Q3 2016.

First Allied Advisory Services reported no remaining Pacific Biosciences position as of Q3 2016 after selling out during the quarter.
First Allied Advisory Services sold 16,669 Pacific Biosciences shares in Q3 2016, an estimated $117K.
First Allied Advisory Services first reported a position in Pacific Biosciences in Q1 2014 and held it in 5 quarters.
First Allied Advisory Services's Pacific Biosciences position peaked at $221K in Q2 2014.
128 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2016.

Based on First Allied Advisory Services's 13F filing for Q3 2016, filed 14 Nov 2016.